Abstract View

Author(s): Deepa Gavit*1, Dhara Patel2, Girishna Patel3, Tejas Patel4, Dhananjay Meshram5

Email(s): 1gavitdeepa05@gmail.com

Address:

    Department of Pharmaceutical Quality Assurance, pioneer pharmacy College Nr.Ajwa Crossing sayajipura, vadodara-390019,Gujrat, India

Published In:   Volume - 5,      Issue - 6,     Year - 2026

DOI: https://doi.org/10.71431/IJRPAS.2026.5621  

 View HTML        View PDF

Please allow Pop-Up for this website to view PDF file.

ABSTRACT:
The pharmaceutical manufacturing industry is rapidly moving toward digital transformation and advanced quality management systems to improve product quality, manufacturing efficiency, and regulatory compliance. Data-driven quality improvement has become an important approach for identifying process variability, reducing human errors, minimizing deviations, and improving overall manufacturing performance. Modern pharmaceutical industries generate large amounts of production and quality-related data through manufacturing execution systems (MES), laboratory information management systems (LIMS), enterprise resource planning (ERP), process analytical technology (PAT), and automated manufacturing equipment. The proper analysis and utilization of this data help industries in making better decisions, improving process control, and maintaining product consistency. Advanced technologies such as artificial intelligence (AI), machine learning (ML), big data analytics, cloud computing, and Industry 4.0 tools are increasingly being implemented in pharmaceutical manufacturing environments. The regulatory authorities it is including the USFDA, WHO, and ICH emphasize data integrity, quality risk management (QRM) and continuous improvement as essential elements of the modern pharmaceutical quality systems. This review article discusses the concept of data-driven quality improvement in pharmaceutical manufacturing environments, major data sources, digital technologies, statistical tools, regulatory perspectives, benefits, challenges, and future opportunities.

Cite this article:
Deepa Gavit, Dhara Patel, Girishna Patel, Tejas Patel, Dhananjay Meshram. Data-Driven Quality Improvement in Pharmaceutical Manufacturing Environment. IJRPAS, June 2026; 5(6): 277-304DOI: https://doi.org/https://doi.org/10.71431/IJRPAS.2026.5621


References not available.

Related Images:



Recent Images



Methyl Red in Materials Engineering: A Systematic Review of Physicochemical, Energetic and Technological Applications Using the PRISMA Methodology
Nature to Laboratory Translation of Indole Scaffolds: Integrating Natural Product Diversity, Sustainable Synthesis, and Evidence Guided Medicinal Chemistry
Antidiuretic Hormone Deficiency and Central Diabetes Insipidus (Arginine Vasopressin Deficiency): Pathophysiology, Etiology, and Contemporary Management Strategies
Mechanistic Evaluation of Acalypha hispida in Psoriasis Using Network Pharmacology and In-vivo Experimental Models
Formulation and Evaluation of Solubility enhanced Aripiprazole Oro Dispersible Film for the improved patient compliance
LipoEdge™ Liposomal Zinc by WBCIL: From Critical Quality Attributes to Bioavailability Validation and Formulation Applications
Network Pharmacology: A Systems Biology Approach to Drug Discovery and Disease Mechanisms
Artificial Intelligence in Pharmaceutical Formulation Development: From Trial-and-Error to Data-Driven Design
Evaluation of In-Vitro Anti-Diabetic Activity And   Antioxidant Activity In Ethanolic and Hydroalcoholic Extract of leaves of Gymnema Sylvestre
Molecular Docking Approaches in Antibacterial Drug Discovery: Computational Insights into Natural Compounds

Tags